Collectively, our results suggest that WNT/β-catenin signaling activation within LNM-ICC blocks CXCL12 production, which is partly mediated through β-catenin-dependent transcriptional repression. This evidence concerns the gene CXCL12 and intrahepatic cholangiocarcinoma.